5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP)

被引：56

作者：

VICKERS, PJ ^{[1
]}

机构：

[1] MERCK FROSST CTR THERAPEUT RES,DEPT BIOCHEM & MOLEC BIOL,MONTREAL,PQ H9R 4P8,CANADA

来源：

JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 1995年 / 12卷 / 2-3期

关键词：

LEUKOTRIENE; 5-LIPOXYGENASE; FLAP; MK-886; MK-591;

D O I：

10.1016/0929-7855(95)00018-L

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：185 / 194

页数：10

共 46 条

[1] 5-LIPOXYGENASE-ACTIVATING PROTEIN STIMULATES THE UTILIZATION OF ARACHIDONIC-ACID BY 5-LIPOXYGENASE [J].

ABRAMOVITZ, M ;

WONG, E ;

COX, ME ;

RICHARDSON, CD ;

LI, C ;

VICKERS, PJ .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 215 (01) :105-111

[2] STRUCTURE AND FUNCTION OF EPIDERMAL GROWTH FACTOR-LIKE REGIONS IN PROTEINS [J].

APPELLA, E ;

WEBER, IT ;

BLASI, F .

FEBS LETTERS, 1988, 231 (01) :1-4

[3] REGULATION OF 5-LIPOXYGENASE AND 5-LIPOXYGENASE-ACTIVATING PROTEIN EXPRESSION IN HL-60 CELLS [J].

BENNETT, CF ;

CHIANG, MY ;

MONIA, BP ;

CROOKE, ST .

BIOCHEMICAL JOURNAL, 1993, 289 :33-39

[4] PHARMACOLOGY OF MK-0591 (3-[1-(4-CHLOROBENZYL)-3-(T-BUTYLTHIO)-5-(QUINOLIN-2-YL-METHOXY)-INDOL-2-YL]-2,2-DIMETHYL PROPANOIC ACID), A POTENT, ORALLY ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITOR [J].

BRIDEAU, C ;

CHAN, C ;

CHARLESON, S ;

DENIS, D ;

EVANS, JF ;

FORDHUTCHINSON, AW ;

FORTIN, R ;

GILLARD, JW ;

GUAY, J ;

GUEVREMONT, D ;

HUTCHINSON, JH ;

JONES, TR ;

LEGER, S ;

MANCINI, JA ;

MCFARLANE, CS ;

PICKETT, C ;

PIECHUTA, H ;

PRASIT, P ;

RIENDEAU, D ;

ROUZER, CA ;

TAGARI, P ;

VICKERS, PJ ;

YOUNG, RN ;

ABRAHAM, WM .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (06) :799-807

[5]

CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929

[6] LEUKOTRIENES AS A TARGET IN ASTHMA THERAPY [J].

CHANARIN, N ;

JOHNSTON, SL .

DRUGS, 1994, 47 (01) :12-24

[7]

CHARLESON S, 1992, MOL PHARMACOL, V41, P873

[8] STRUCTURAL REQUIREMENTS FOR THE BINDING OF FATTY-ACIDS TO 5-LIPOXYGENASE-ACTIVATING PROTEIN [J].

CHARLESON, S ;

EVANS, JF ;

LEGER, S ;

PERRIER, H ;

PRASIT, P ;

WANG, ZY ;

VICKERS, PJ .

EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (03) :275-280

[9]

CLAESSON HE, 1993, J LIPID MEDIATOR, V6, P15

[10]

COFFEY M, 1992, J BIOL CHEM, V267, P570

← 1 2 3 4 5 →